Rhabdomyolysis Associated With Olanzapine Treatment in a Child With Autism

Children with autism often display difficult behaviors including tantrums, extreme irritability, and physical aggression. There is emerging evidence that olanzapine is useful in decreasing these disruptive behaviors. The most common adverse effects are weight gain and short-term sedation. On the oth...

Full description

Saved in:
Bibliographic Details
Published in:Pediatric emergency care Vol. 26; no. 1; pp. 41 - 42
Main Authors: Karakaya, Pakize, Yiş, Uluç, Kurul, Semra Hz, Türkmen, Mehmet Atilla
Format: Journal Article
Language:English
Published: Hagerstown, MD Lippincott Williams & Wilkins, Inc 01-01-2010
Lippincott Williams & Wilkins
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Children with autism often display difficult behaviors including tantrums, extreme irritability, and physical aggression. There is emerging evidence that olanzapine is useful in decreasing these disruptive behaviors. The most common adverse effects are weight gain and short-term sedation. On the other hand, olanzapine rarely causes rhabdomyolysis. We report a case with rhabdomyolysis in an autistic child just after 2 doses of olanzapine treatment. Initial creatine kinase value was 30,690 IU/L (range, 5-130 U/L), and rhabdomyolysis resolved with hydration and alkalinization over 7 days. Monitoring serum creatine kinase levels may be useful in pediatric cases after initiation of olanzapine treatment.
AbstractList Children with autism often display difficult behaviors including tantrums, extreme irritability, and physical aggression. There is emerging evidence that olanzapine is useful in decreasing these disruptive behaviors. The most common adverse effects are weight gain and short-term sedation. On the other hand, olanzapine rarely causes rhabdomyolysis. We report a case with rhabdomyolysis in an autistic child just after 2 doses of olanzapine treatment. Initial creatine kinase value was 30,690 IU/L (range, 5-130 U/L), and rhabdomyolysis resolved with hydration and alkalinization over 7 days. Monitoring serum creatine kinase levels may be useful in pediatric cases after initiation of olanzapine treatment.
Author Kurul, Semra Hz
Türkmen, Mehmet Atilla
Karakaya, Pakize
Yiş, Uluç
AuthorAffiliation From the Department of Pediatrics, Divisions of †Pediatric Neurology, and ‡Pediatric Nephrology, Department of Pediatrics, School of Medicine, Dokuz Eylül University, İzmir, Turkey
AuthorAffiliation_xml – name: From the Department of Pediatrics, Divisions of †Pediatric Neurology, and ‡Pediatric Nephrology, Department of Pediatrics, School of Medicine, Dokuz Eylül University, İzmir, Turkey
Author_xml – sequence: 1
  givenname: Pakize
  surname: Karakaya
  fullname: Karakaya, Pakize
  organization: From the Department of Pediatrics, Divisions of †Pediatric Neurology, and ‡Pediatric Nephrology, Department of Pediatrics, School of Medicine, Dokuz Eylül University, İzmir, Turkey
– sequence: 2
  givenname: Uluç
  surname: Yiş
  fullname: Yiş, Uluç
– sequence: 3
  givenname: Semra
  surname: Kurul
  middlename: Hz
  fullname: Kurul, Semra Hz
– sequence: 4
  givenname: Mehmet
  surname: Türkmen
  middlename: Atilla
  fullname: Türkmen, Mehmet Atilla
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=22333522$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/20065830$$D View this record in MEDLINE/PubMed
BookMark eNpdkN1q3DAQRkVJaTZp36AU35ReOR15LFu6XJakPwQSQkovhSyPsVrZ3ko2Yfv01TZuA4GBgdGZb8Q5YyfjNBJjbzlccFD1x9vL3QU0wJGQS25RmaJ4wTZcoMjTQJywDdSlygWv-Ck7i_EHQHpEfMVOC4BKSIQN-3rXm6adhsPkD9HFbBvjZJ2Zqc2-u7nPbrwZf5u9Gym7D2TmgcY5c2Nmsl3v_Aptl9nF4TV72Rkf6c3az9m3q8v73ef8-ubTl932OrcoOeRVhaYDAINWdWWhKlJWKl6CKLtGKWGAjJRUoG0kSlXLDtsSVVu3UNeWLJ6zD4-5-zD9WijOenDRkk8_pWmJukaUmHLLRJaPpA1TjIE6vQ9uMOGgOeijRJ0k6ucS09q79cDSDNT-X_pnLQHvV8BEa3wXzGhdfOKKZFn8DVrvP0x-phB_-uWBgu7J-LnXyUHKq0ReAIdjQQ7Hjn8AABOLPg
CitedBy_id crossref_primary_10_1016_j_psym_2013_05_003
crossref_primary_10_1089_cap_2011_0134
crossref_primary_10_1177_03000605211047761
crossref_primary_10_1203_PDR_0b013e318212f16b
crossref_primary_10_1038_mp_2010_136
crossref_primary_10_1136_bcr_2022_254377
crossref_primary_10_1080_14740338_2020_1820985
crossref_primary_10_1002_ccr3_5951
crossref_primary_10_1002_ddrr_118
crossref_primary_10_1016_j_nbd_2024_106520
crossref_primary_10_1016_j_nmd_2013_03_008
crossref_primary_10_1177_0897190013516509
Cites_doi 10.1177/0960327106073832
10.1345/aph.10370
10.1345/aph.1H527
10.1345/aph.18282
10.1089/cap.2007.0101
10.1016/0893-133X(95)00276-J
10.1016/0022-510X(76)90046-0
10.1097/00152193-200030090-00034
10.2165/00003088-199937030-00001
ContentType Journal Article
Copyright 2010 Lippincott Williams & Wilkins, Inc.
2015 INIST-CNRS
Copyright_xml – notice: 2010 Lippincott Williams & Wilkins, Inc.
– notice: 2015 INIST-CNRS
DBID IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.1097/PEC.0b013e3181c39a22
DatabaseName Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE

Database_xml – sequence: 1
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1535-1815
EndPage 42
ExternalDocumentID 10_1097_PEC_0b013e3181c39a22
20065830
22333522
00006565-201001000-00010
Genre Journal Article
Case Reports
GroupedDBID -
.XZ
.Z2
0R
123
4Q1
4Q2
4Q3
53G
5RE
5VS
71W
8L-
AAPBV
AAQQT
AARTV
AAWTL
AAYEP
ABBUW
ABFLS
ABPPZ
ABXVJ
ABZAD
ACDDN
ACEWG
ACGFS
ACWDW
ACWRI
ACXNZ
ADFPA
ADNKB
AE3
AENEX
AFFNX
AHULI
AHVBC
AJIOK
AJNYG
ALMA_UNASSIGNED_HOLDINGS
AMJPA
ASCII
AWKKM
BQLVK
C45
CS3
DU5
DUNZO
E.X
EBS
EJD
EX3
F5P
FL-
GJ
H0
H0~
HZ
IN
IN~
JF9
JG8
JK3
JK8
K8S
KD2
L-C
N9A
N~M
O9-
OAG
OAH
OCUKA
ODA
OHASI
OLG
OLW
ONV
OPUJH
ORVUJ
OUVQU
OVD
OVDNE
OVOZU
OWW
OWY
OXXIT
P-K
P2P
R58
RIG
RLZ
RSW
S4R
S4S
V2I
WOQ
WOW
X3V
X3W
XZ
Z2
ZGI
ZXP
---
.-D
.3C
.GJ
0R~
AAHPQ
AAJCS
ABASU
ABDIG
ACGFO
ACILI
ADGGA
AE6
AEBDS
AEETU
AFDTB
AJNWD
AKALU
ALMTX
AMKUR
AMNEI
AOHHW
BS7
DIWNM
EEVPB
FCALG
GNXGY
GQDEL
HZ~
IKREB
IQODW
K-A
K-F
ODMTH
OHYEH
OJAPA
OWU
OWV
OWX
OWZ
T8P
TEORI
TSPGW
VVN
W3M
XXN
XYM
YFH
ZFV
ZZMQN
AAAAV
AAIQE
AASCR
AAUEB
ABJNI
ABVCZ
ACXJB
ADHPY
AFEXH
AFSOK
AHQNM
AINUH
AJZMW
CGR
CUY
CVF
ECM
EIF
HLJTE
NPM
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c3810-663af000a3c9f4296e9c8914054fb995a0ea88e23cb838978f3d439d7d077cec3
ISSN 0749-5161
IngestDate Fri Aug 16 00:51:27 EDT 2024
Fri Aug 23 03:34:39 EDT 2024
Sat Sep 28 07:59:01 EDT 2024
Sun Oct 22 16:09:59 EDT 2023
Thu Aug 13 19:47:41 EDT 2020
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Human
Dibenzodiazepine derivatives
Intensive care
Atypical antipsychotic
Olanzapine
Neuroleptic
Psychotropic
Dopamine antagonist
Serotonin antagonist
Developmental disorder
Serotonine receptor
Rhabdomyolysis
Thienobenzodiazepine derivatives
Autism
Striated muscle disease
D2 Dopamine receptor
Treatment
Child
Resuscitation
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c3810-663af000a3c9f4296e9c8914054fb995a0ea88e23cb838978f3d439d7d077cec3
Notes ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
PMID 20065830
PQID 733832964
PQPubID 23479
PageCount 2
ParticipantIDs proquest_miscellaneous_733832964
crossref_primary_10_1097_PEC_0b013e3181c39a22
pubmed_primary_20065830
pascalfrancis_primary_22333522
wolterskluwer_health_00006565-201001000-00010
ProviderPackageCode OVOZU
L-C
C45
AARTV
ADFPA
ASCII
OLG
ODA
ABZAD
ABBUW
JK3
ADNKB
JK8
H0~
8L-
JG8
OLW
OHASI
AHVBC
AJNYG
FL-
K8S
AJIOK
OPUJH
V2I
.XZ
S4R
S4S
4Q1
DUNZO
OAG
4Q2
OVDNE
4Q3
AMJPA
OAH
OVD
71W
AHULI
ACEWG
.Z2
AWKKM
OUVQU
ONV
ORVUJ
X3V
X3W
ACDDN
ACWRI
E.X
OWW
OCUKA
OWY
ACXNZ
ABXVJ
IN~
KD2
OXXIT
ACWDW
JF9
PublicationCentury 2000
PublicationDate 2010-January
2010
2010-Jan
2010-01-00
20100101
PublicationDateYYYYMMDD 2010-01-01
PublicationDate_xml – month: 01
  year: 2010
  text: 2010-January
PublicationDecade 2010
PublicationPlace Hagerstown, MD
PublicationPlace_xml – name: Hagerstown, MD
– name: United States
PublicationTitle Pediatric emergency care
PublicationTitleAlternate Pediatr Emerg Care
PublicationYear 2010
Publisher Lippincott Williams & Wilkins, Inc
Lippincott Williams & Wilkins
Publisher_xml – name: Lippincott Williams & Wilkins, Inc
– name: Lippincott Williams & Wilkins
References Stachnik (R2-10-20100109) 2007; 41
Waring (R3-10-20100109) 2006; 25
Koren (R9-10-20100109) 1998; 21
Meltzer (R6-10-20100109) 1996; 15
Strawn (R5-10-20100109) 2008; 18
Shuster (R7-10-20100109) 2000; 30
Callaghan (R1-10-20100109) 1999; 37
Meltzer (R8-10-20100109) 1976; 28
Rosebraugh (R4-10-20100109) 2001; 35
Marcus (R10-10-20100109) 1999; 33
References_xml – volume: 25
  start-page: 735
  year: 2006
  ident: R3-10-20100109
  publication-title: Hum Exp Toxicol
  doi: 10.1177/0960327106073832
  contributor:
    fullname: Waring
– volume: 35
  start-page: 1020
  year: 2001
  ident: R4-10-20100109
  publication-title: Ann Pharmacother
  doi: 10.1345/aph.10370
  contributor:
    fullname: Rosebraugh
– volume: 21
  start-page: 262
  year: 1998
  ident: R9-10-20100109
  publication-title: Clin Neuropharmacol
  contributor:
    fullname: Koren
– volume: 41
  start-page: 626
  year: 2007
  ident: R2-10-20100109
  publication-title: Ann Pharmacother
  doi: 10.1345/aph.1H527
  contributor:
    fullname: Stachnik
– volume: 33
  start-page: 697
  year: 1999
  ident: R10-10-20100109
  publication-title: Ann Pharmacotherapy
  doi: 10.1345/aph.18282
  contributor:
    fullname: Marcus
– volume: 18
  start-page: 116
  year: 2008
  ident: R5-10-20100109
  publication-title: J Child Adolesc Psychopharmacol
  doi: 10.1089/cap.2007.0101
  contributor:
    fullname: Strawn
– volume: 15
  start-page: 395
  year: 1996
  ident: R6-10-20100109
  publication-title: Neuropsychopharmacology
  doi: 10.1016/0893-133X(95)00276-J
  contributor:
    fullname: Meltzer
– volume: 28
  start-page: 41
  year: 1976
  ident: R8-10-20100109
  publication-title: J Neurol Sci
  doi: 10.1016/0022-510X(76)90046-0
  contributor:
    fullname: Meltzer
– volume: 30
  start-page: 87
  issue: 9
  year: 2000
  ident: R7-10-20100109
  publication-title: Nursing
  doi: 10.1097/00152193-200030090-00034
  contributor:
    fullname: Shuster
– volume: 37
  start-page: 177
  year: 1999
  ident: R1-10-20100109
  publication-title: Pharmacokinet
  doi: 10.2165/00003088-199937030-00001
  contributor:
    fullname: Callaghan
SSID ssj0015333
Score 1.9762977
Snippet Children with autism often display difficult behaviors including tantrums, extreme irritability, and physical aggression. There is emerging evidence that...
SourceID proquest
crossref
pubmed
pascalfrancis
wolterskluwer
SourceType Aggregation Database
Index Database
Publisher
StartPage 41
SubjectTerms Adolescent
Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy
Autistic Disorder - drug therapy
Benzodiazepines - adverse effects
Benzodiazepines - therapeutic use
Biological and medical sciences
Blood. Blood and plasma substitutes. Blood products. Blood cells. Blood typing. Plasmapheresis. Apheresis
Creatine Kinase - blood
Fluid Therapy - methods
Follow-Up Studies
Humans
Intensive care medicine
Male
Medical sciences
Rhabdomyolysis - chemically induced
Rhabdomyolysis - enzymology
Rhabdomyolysis - therapy
Serotonin Uptake Inhibitors - adverse effects
Serotonin Uptake Inhibitors - therapeutic use
Transfusions. Complications. Transfusion reactions. Cell and gene therapy
Title Rhabdomyolysis Associated With Olanzapine Treatment in a Child With Autism
URI http://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&AN=00006565-201001000-00010
https://www.ncbi.nlm.nih.gov/pubmed/20065830
https://search.proquest.com/docview/733832964
Volume 26
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3Pb9MwFLZKJyEkNPGbDph84FYZkjhZ7GNUglq2AiqtYKfISRytok2rtRVifz3PseM0oxJw4BJVqdO6fq_Pn5-_9xmh15nIU5gGOGGscIjPckl44eTEpUIpdHEW-Ko4efgl_PiNvYv9uNOpD9Np7v1XS8M9sLWqnP0Ha9sPhRvwGmwOV7A6XP_K7pMrkear5c-V1hqphx9w5VeVcv20ADAo1gpbTi3HfF72hRY51o0i6J9RFjS41Z7o0Ze2XlORxmy8jibReXQZ1aD0xr5zOarIgbPFrtqTbw5TmU1mF1XuVS6vRX84v7FJBNWQDybn47jiIIzl1VJu-9HWHJBksxSGqVrlJw7oTFT5iflCkYD2wl3ocxK4Wpr9jazDcUAAgwT78VpX2Lf8Ugdf392bxrVm128ThBYe_hwPmgywm1EudHF0W4_71jxp2YuAqFSlGkz8Rx6EN6-LjqLB6GJkd68AQhv5V_2L6pJNHr499M0tSHR_LTbw7yz0sSqH1j3Q5sdKUSk236tKij08NH2Ajs1CBkfaAx-ijiwfobtjQ9V4jD60HRE3joiVj-HGEbF1RDwvscCVI-pG2hGfoNn7eDoYEnNwB8mUYBwBFCsKmGsFzXgBgOdM8oxxWMoHfpFyHghHCsakR7OUAWAOWUFzAMZ5mDthmMmMPkXdclXK5wg71GeOJ2ERkFO_gKf8LHXpGS_ClArh8R4i9dgla63PktS8Chjr5PZY99Bpa4DtQ7VRewjXI55ApFXbZ6KUq90mCVU2R7EUeuiZtkTzcIXkqQO9aZkm0cXMSYUKA8UndZTmmVFzcJ2TP_XmBbqn6Soq5_cSdbfXO_kK3dnku1PjdL8Ad6KtJQ
link.rule.ids 315,782,786,4028,27932,27933,27934,64549,64569,65344,65364
linkProvider Ovid
linkToHtml http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwvV3db9MwELegkwAJ8c0og-EHlDdDGieN_dCHrE0pYysTDRo8RU5sa9NYUpF2E_89d_nYKIIHXpAiJQ9nycmdcz_f7-5MyOtc6QzcgGRCWJf5QhsmravZgCvs0CVF4GNx8mwRzr-ISYxtcrpcVSw-q5Zv8Fb_pvEBj8PBfWEy2l848_h4MSqc8WI8-uocRe_iOkyNSRLOZFRe2JUTzev0K8ApAUOqF6-6eBoLsbaGAR_6PbIVTSfJ3hXdAJin7dcpWQAYqKuxk-Hbo3h8HSwc5Fwqz9vwYXeXqoLPaZtzMP4EVEHmskTuuzqrU99_cWDT-__p1R-Qey3CpVFjkg_JDVM8IrcOWw7_Mdn_dKIyXZ7_KOtuKLQzEKPp8enqhH78BnBVLUGWJl0WPD0tqKJ1G-ZGKIL1Up0_IZ-ncTKesfZEB5ZjJzEG8EZZmI_iubTgCYdG5kLCHi_wbSZloFyjhDAezzMBSCoUlmtATDrUbhjmJudPSa8oC_OMUJf7wvUMoEPNfQuj_Dwb8KG0YcaV8mSfsE5H6bJp3JF2hDvoNP1dp32yu6HIq0GAn7AuDQRop9kUliDyKqow5bpKQ9zmI33dJ9uNxq8H1xCPuzCbDRNImyrX9G_qev6P8q_I7VlyeJAevJ9_2CF3mhQHjBO9IL3V97V5SW5Wer3b2v1PH3YHhw
linkToPdf http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwvV1Lb9QwELaglSokRHmzFIoPKDdDNk429iGHdDdLKRBW7KKWU-TEtlpBkxXZBfXfdyaPlkVw4IIUKTmMJcszk_nsb2ZMyMtC6RzCgGRCWJf5QhsmravZkCvs0CVF4GNx8uE8TE_EJME2OT2Dj8Vn9fIVvprfNH7gdTi4L1xER3NnPB9HX5w0OZ5HqTOL3yTNMTUmSTizyTS6cCZR9cOunDhtkrAArQQMCV98mhJqLMfaHgFsABfYjqeTxcEV6QDIp-vaKVkASKivtJPh61kyvj4yHBZcKs_biGS3l6qGRbXtbRh_gqsg87NCBrz-2iTA_xLGprv_dQHukjsd2qVxa573yA1T3ic7Hzo-_wE5-nSqcl2dX1RNZxTaG4vR9PhsdUo_fgPoqpYgSxd9Rjw9K6miTUvmVigG36nPH5LP02QxPmTd7Q6swK5iDKCOsjAfxQtpISqOjCyEhP1e4NtcykC5RglhPF7kAlBVKCzXgJ50qN0wLEzBH5GtsirNE0Jd7gvXM4AUNfctjPKLfMhH0oY5V8qTA8J6TWXLtolH1pPvoNnsd80OyP6GOq8GAZbCGjUQoL1-M3BH5FhUaap1nYW45Ucqe0Aet3q_HtzAPe7CbDYMIWsrXrO_qevpP8q_IDtgCdn7t-m7PXKrzXbAI6NnZGv1fW2ek5u1Xu93xn8JB1gKaQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Rhabdomyolysis+Associated+With+Olanzapine+Treatment+in+a+Child+With+Autism&rft.jtitle=Pediatric+emergency+care&rft.au=KARAKAYA%2C+Pakize&rft.au=YIS%2C+Ulu%C3%A7&rft.au=KURUL%2C+Semra+Hiz&rft.au=T%C3%9CRKMEN%2C+Mehmet+Atilla&rft.date=2010&rft.pub=Lippincott+Williams+%26+Wilkins&rft.issn=0749-5161&rft.eissn=1535-1815&rft.volume=26&rft.issue=1&rft.spage=41&rft.epage=42&rft_id=info:doi/10.1097%2FPEC.0b013e3181c39a22&rft.externalDBID=n%2Fa&rft.externalDocID=22333522
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0749-5161&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0749-5161&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0749-5161&client=summon